Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000903827 | SCV001048311 | benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001796814 | SCV002067866 | benign | not specified | 2021-06-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495465 | SCV002802130 | likely benign | McCune-Albright syndrome; Pseudohypoparathyroidism type 1C; Pseudohypoparathyroidism type 1B; Pseudopseudohypoparathyroidism; Progressive osseous heteroplasia; Pituitary adenoma 3, multiple types; ACTH-independent macronodular adrenal hyperplasia 1; Pseudohypoparathyroidism type I A | 2021-11-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541903 | SCV004796127 | benign | GNAS-related disorder | 2020-11-17 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000903827 | SCV002036588 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001796814 | SCV002037950 | benign | not specified | no assertion criteria provided | clinical testing |